Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2017

View Archived Issues

Fujifilm to begin clinical testing of FF-10832 for advanced solid tumors next year

FDA issues refusal to file letter for SteadyMed's Trevyent NDA

Akcea announces NDA submission for volanesorsen in familial chylomicronemia syndrome

Bayer submits BLA to FDA for BAY-94-9027

Sunovion files NDA for dasotraline to treat ADHD

Daiichi Sankyo terminates agreement with Charleston Laboratories

Topline results from Asian REDUCER trial of mirogabalin in diabetic peripheral neuropathic pain

Sumitomo Dainippon Pharma submits an application in Japan for an additional indication for Trerief

Bristol-Myers Squibb explores adaptor-associated kinase 1 as a target for neuropathic pain

Thermo Fisher forms European Immuno-Oncology Consortium

Serum APEX found a marker of myocarditis severity

European Commission approves pediatric formulation of Mimpara

Mochida compound shows effective targeting of FFAR1 for diabetes

Horizon Discovery completes acquisition of GE Healthcare Dharmacon

Aptevo and MorphoSys end partnership for MOR-209

FDA awards fast track designation to Iovance's LN-144 for advanced melanoma

Taisho Pharmaceutical presents 20-HETE synthase inhibitors

Heptares begins leukotriene receptor modulator collaboration with Juntendo University

ImMAGE Biotherapeutics terminates operations

Roche and Genentech patent new Janus kinase inhibitors

Sprint Bioscience AB divulges PIK3C3 inhibitors

RegeneRx completes license expansion agreement with GtreeBNT for RGN-137

Oragenics initiates phase II trial of AG-013 for oral mucositis

Janssen Vaccines & Prevention BV patent adenoviral vectors for treating malaria

Penn State Research Foundation divulges CCK2 receptor-targeting DNA aptamers

Novel compounds target MYC via G-quadruplex in the promoter region

Janssen Biotech terminates duvortuxizumab agreement with MacroGenics

Novel susceptibility loci identified for aortic aneurysm in Japanese individuals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...